These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2589233

  • 1. Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo.
    Pollera CF, Nardi M, Marolla P, Pinnaró P, Terzoli E, Giannarelli D.
    Am J Clin Oncol; 1989 Dec; 12(6):524-9. PubMed ID: 2589233
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High-dose metoclopramide and dexamethasone as an antiemetic in chemotherapy of breast cancer.
    Gez E, Goodman S, Isacson R, Gerra C, Sulkes A.
    Oncology; 1986 Dec; 43(3):173-5. PubMed ID: 3754627
    [Abstract] [Full Text] [Related]

  • 4. Methylprednisolone versus metoclopramide as antiemetic treatment in patients receiving adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) chemotherapy: a randomized crossover blind study.
    Gez E, Sulkes A, Ochayon L, Gera C, Nathan S, Cass Y, Rubello E, Biran S.
    J Chemother; 1989 Dec; 1(6):365-8. PubMed ID: 2693621
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized open cross-over trial between metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting.
    Cognetti F, Pinnarò P, Carlini P, Conti EM, Cortese M, Pollera CF.
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):183-7. PubMed ID: 6368241
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin.
    Pollera CF, Nardi M, Marolla P, Carlini P.
    Cancer Chemother Pharmacol; 1987 Feb; 19(4):335-8. PubMed ID: 3297376
    [Abstract] [Full Text] [Related]

  • 9. An audit of antiemetic use with CMF chemotherapy.
    Brown RS, Brown TK, Hoare D, Gaze MN.
    Clin Oncol (R Coll Radiol); 1998 Feb; 10(5):313-7. PubMed ID: 9848332
    [Abstract] [Full Text] [Related]

  • 10. The antiemetic efficacy of methylprednisolone compared with metoclopramide in outpatients receiving adjuvant CMF chemotherapy for breast cancer: a randomized trial.
    Campora E, Chiara S, Bruzzi P, Scarsi P, Rosso R.
    Tumori; 1985 Oct 31; 71(5):459-62. PubMed ID: 3904102
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study.
    Roila F, Basurto C, Minotti V, Ballatori E, Tonato M, Del Favero A.
    Oncology; 1988 Oct 31; 45(5):346-9. PubMed ID: 3412741
    [Abstract] [Full Text] [Related]

  • 13. Alizapride alone or alizapride-dexamethasone compared with metoclopramide-dexamethasone in patients at high risk of acute emesis after cisplatin. A randomized cross-over study.
    Pollera CF, Nardi M, Marolla P, Calabresi F.
    Acta Oncol; 1991 Oct 31; 30(6):725-9. PubMed ID: 1958393
    [Abstract] [Full Text] [Related]

  • 14. Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy.
    Niiranen A, Mattson K.
    Am J Clin Oncol; 1987 Aug 31; 10(4):325-9. PubMed ID: 3039831
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis.
    Grunberg SM, Akerley WL, Krailo MD, Johnson KB, Baker CR, Cariffe PA.
    Cancer Invest; 1986 Aug 31; 4(5):379-85. PubMed ID: 3801953
    [Abstract] [Full Text] [Related]

  • 17. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct 31; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.